Julia Perez-Martinez
Sevilla, AN, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Phase II study of magrolimab combined with docetaxel in previously treated metastatic advanced solid tumors.
Journal: Frontiers in oncology
Published: January 12, 2026
Efficacy of NAMPT Inhibitors in Pancreatic Cancer After Stratification by MAP17 (PDZK1IP1) Levels.
Journal: Cancers
Published: June 03, 2025
Efficacy and safety of glecirasib in solid tumors with KRAS G12C mutation: A pooled analysis of two phase I/II trials.
Journal: Cancer communications (London, England)
Published: March 24, 2025
Regorafenib combined with immune checkpoint inhibitors versus regorafenib monotherapy as a late-line treatment for metastatic colorectal cancer: a single-center, retrospective cohort study.
Journal: Journal of gastrointestinal oncology
Published: June 20, 2024
Targeted Treatment against Cancer Stem Cells in Colorectal Cancer.
Journal: International journal of molecular sciences
Published: April 27, 2024
KRAS G12C inhibitors in metastatic colorectal cancer: a tale of two targets.
Journal: Translational gastroenterology and hepatology
Published: April 12, 2024
Effectiveness, safety, and prognostic factors of trifluridine/tipiracil for the treatment of patients with metastatic colorectal cancer in routine clinical practice.
Journal: Journal of gastrointestinal oncology
Published: May 25, 2022
The safety of trifluridine and tipiracil for the treatment of metastatic colorectal cancer.
Journal: Expert opinion on drug safety
Published: May 11, 2018
Prognostic relevance of Src activation in stage II-III colon cancer.
Journal: Human pathology
Published: February 01, 2017
Gene expression profile predictive of response to chemotherapy in metastatic colorectal cancer.
Journal: Oncotarget
Published: September 26, 2014
Showing 1-11 of 11
Last Updated: 09/26/2026